- Home
- AUTL vs MSEX Comparison
AUTL vs MSEX Comparison
Compare AUTL & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- MSEX
- Stock Information
- Founded
- AUTL 2014
- MSEX 1897
- Country
- AUTL United Kingdom
- MSEX United States
- Employees
- AUTL N/A
- MSEX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- MSEX Water Supply
- Sector
- AUTL Health Care
- MSEX Utilities
- Exchange
- AUTL Nasdaq
- MSEX Nasdaq
- Market Cap
- AUTL 1.1B
- MSEX 1.2B
- IPO Year
- AUTL 2018
- MSEX N/A
- Fundamental
- Price
- AUTL $2.84
- MSEX $65.85
- Analyst Decision
- AUTL Strong Buy
- MSEX Hold
- Analyst Count
- AUTL 3
- MSEX 1
- Target Price
- AUTL $10.20
- MSEX $61.00
- AVG Volume (30 Days)
- AUTL 2.6M
- MSEX 86.6K
- Earning Date
- AUTL 11-12-2024
- MSEX 10-31-2024
- Dividend Yield
- AUTL N/A
- MSEX 2.06%
- EPS Growth
- AUTL N/A
- MSEX 24.58
- EPS
- AUTL N/A
- MSEX 2.30
- Revenue
- AUTL $10,091,000.00
- MSEX $183,372,000.00
- Revenue This Year
- AUTL $816.67
- MSEX $15.27
- Revenue Next Year
- AUTL $374.47
- MSEX $6.33
- P/E Ratio
- AUTL N/A
- MSEX $28.73
- Revenue Growth
- AUTL 82.71
- MSEX 10.14
- 52 Week Low
- AUTL $2.69
- MSEX $45.42
- 52 Week High
- AUTL $7.45
- MSEX $73.47
- Technical
- Relative Strength Index (RSI)
- AUTL 32.80
- MSEX 50.26
- Support Level
- AUTL $3.24
- MSEX $64.49
- Resistance Level
- AUTL $3.25
- MSEX $67.39
- Average True Range (ATR)
- AUTL 0.33
- MSEX 1.89
- MACD
- AUTL -0.08
- MSEX -0.20
- Stochastic Oscillator
- AUTL 10.49
- MSEX 38.31
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.